BCAB · BioAtla Inc.
1.68
USDUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
US$3.19M
PE
0.00
EV/EBITDA
N/A
DIV Yield
0%
Payout Ratio
0%
MQV Rating
5Very Weak
As at 22/09/2026 10:24:02 AM
Price Chart
Description
- All-Companies
- Hammer Bullish
Key Fundamentals
EPS 3 yr Growth
-63.00%
EBITDA Margin
NaN%
Operating Cashflow
-$48m
Free Cash Flow Return
0.00%
ROIC
0.00%
Interest Coverage
N/A
Quick Ratio
0.40
Performance
52 weeks range
Low 0.12 - 6.52
Trade Value (12mth)
US$147,856.00
1 week
19.33%
1 month
-43.71%
YTD
235.08%
1 year
187.83%
All time high
76.63
Additional Data
Shares Outstanding (Fully Diluted)
2m
HALO Sector
Healthcare
Next Company Report Date
25-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Very Weak
Earnings
Very Weak
Growth
Earnings
Very Weak
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Valuation
Value
Consensus
Yield
News & Announcements
| Date | Event |
14 August 26EDG | |
14 August 26EDG | |
17 July 26EDG | |
17 July 26EDG | |
16 May 26EDG |
Key Stakeholders
| Name | Title |
| Acorn Capital Advisors LLC | Private Company |
| Jay M. Short | Individual |
| Opoka Investment Fund Co. | Private Company |
| Eric Sievers | Individual |
| Christian Vasquez | Individual |
